These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 21151599)
1. Evidence supporting a role for N-(3-formyl-3,4-dehydropiperidino)lysine accumulation in Müller glia dysfunction and death in diabetic retinopathy. Yong PH; Zong H; Medina RJ; Limb GA; Uchida K; Stitt AW; Curtis TM Mol Vis; 2010 Dec; 16():2524-38. PubMed ID: 21151599 [TBL] [Abstract][Full Text] [Related]
2. Müller glial dysfunction during diabetic retinopathy in rats is reduced by the acrolein-scavenging drug, 2-hydrazino-4,6-dimethylpyrimidine. McDowell RE; Barabas P; Augustine J; Chevallier O; McCarron P; Chen M; McGeown JG; Curtis TM Diabetologia; 2018 Dec; 61(12):2654-2667. PubMed ID: 30112688 [TBL] [Abstract][Full Text] [Related]
3. Müller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products. Curtis TM; Hamilton R; Yong PH; McVicar CM; Berner A; Pringle R; Uchida K; Nagai R; Brockbank S; Stitt AW Diabetologia; 2011 Mar; 54(3):690-8. PubMed ID: 21116609 [TBL] [Abstract][Full Text] [Related]
4. Diabetes Impairs the Aldehyde Detoxifying Capacity of the Retina. McDowell RE; McGahon MK; Augustine J; Chen M; McGeown JG; Curtis TM Invest Ophthalmol Vis Sci; 2016 Sep; 57(11):4762-71. PubMed ID: 27618414 [TBL] [Abstract][Full Text] [Related]
5. Localization of Acrolein-Lysine Adduct in Fibrovascular Tissues of Proliferative Diabetic Retinopathy. Dong Y; Noda K; Murata M; Yoshida S; Saito W; Kanda A; Ishida S Curr Eye Res; 2017 Jan; 42(1):111-117. PubMed ID: 27249374 [TBL] [Abstract][Full Text] [Related]
6. Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology. Berner AK; Brouwers O; Pringle R; Klaassen I; Colhoun L; McVicar C; Brockbank S; Curry JW; Miyata T; Brownlee M; Schlingemann RO; Schalkwijk C; Stitt AW Diabetologia; 2012 Mar; 55(3):845-54. PubMed ID: 22143324 [TBL] [Abstract][Full Text] [Related]
7. Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE). Zong H; Ward M; Madden A; Yong PH; Limb GA; Curtis TM; Stitt AW Diabetologia; 2010 Dec; 53(12):2656-66. PubMed ID: 20835858 [TBL] [Abstract][Full Text] [Related]
8. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. Barber AJ; Antonetti DA; Gardner TW Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253 [TBL] [Abstract][Full Text] [Related]
9. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy. Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628 [TBL] [Abstract][Full Text] [Related]
11. Altered expression of aquaporins 1 and 4 coincides with neurodegenerative events in retinas of spontaneously diabetic Torii rats. Fukuda M; Nakanishi Y; Fuse M; Yokoi N; Hamada Y; Fukagawa M; Negi A; Nakamura M Exp Eye Res; 2010 Jan; 90(1):17-25. PubMed ID: 19748503 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of N (epsilon)-(3-formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy. Zhang X; Lai Y; McCance DR; Uchida K; McDonald DM; Gardiner TA; Stitt AW; Curtis TM Diabetologia; 2008 Sep; 51(9):1723-30. PubMed ID: 18587559 [TBL] [Abstract][Full Text] [Related]
13. Glial reactivity, an early feature of diabetic retinopathy. Rungger-Brändle E; Dosso AA; Leuenberger PM Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1971-80. PubMed ID: 10845624 [TBL] [Abstract][Full Text] [Related]
14. The role lipid aldehydes and ALEs in the pathogenesis of diabetic retinopathy. Curtis T Free Radic Biol Med; 2014 Oct; 75 Suppl 1():S8. PubMed ID: 26461421 [TBL] [Abstract][Full Text] [Related]
15. Expression of aquaporin 4 and Kir4.1 in diabetic rat retina: treatment with minocycline. Zhang Y; Xu G; Ling Q; Da C J Int Med Res; 2011; 39(2):464-79. PubMed ID: 21672350 [TBL] [Abstract][Full Text] [Related]
16. Expression of acute-phase response proteins in retinal Müller cells in diabetes. Gerhardinger C; Costa MB; Coulombe MC; Toth I; Hoehn T; Grosu P Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):349-57. PubMed ID: 15623795 [TBL] [Abstract][Full Text] [Related]
17. Loss of X-box binding protein 1 in Müller cells augments retinal inflammation in a mouse model of diabetes. Yang J; Chen C; McLaughlin T; Wang Y; Le YZ; Wang JJ; Zhang SX Diabetologia; 2019 Mar; 62(3):531-543. PubMed ID: 30612139 [TBL] [Abstract][Full Text] [Related]
18. Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy. McVicar CM; Hamilton R; Colhoun LM; Gardiner TA; Brines M; Cerami A; Stitt AW Diabetes; 2011 Nov; 60(11):2995-3005. PubMed ID: 21911748 [TBL] [Abstract][Full Text] [Related]
19. Müller cell changes in human diabetic retinopathy. Mizutani M; Gerhardinger C; Lorenzi M Diabetes; 1998 Mar; 47(3):445-9. PubMed ID: 9519752 [TBL] [Abstract][Full Text] [Related]
20. Diabetes-Induced Inflammation and Vascular Alterations in the Goto-Kakizaki Rat Retina. Hachana S; Pouliot M; Couture R; Vaucher E Curr Eye Res; 2020 Aug; 45(8):965-974. PubMed ID: 31902231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]